Pseudomonas

Pathogenesis of Bacterial Infections in Animals: Fourth Edition

Volumn , Issue , 2010, Pages 443-468

  Westman, E L ^a   Matewish, J M ^a   Lam, J S ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Division of pathogenesis of P. aeruginosa infections bacterial colonization, multiplication, systemic disease; Host immune defense mechanisms exerting bactericidal effects; Pilus deficient strains causing epithelial cell damage; Pseudomonas; Pseudomonas aeruginosa opportunistic pathogen; Pseudomonas species remarkable nutritional diversity

Indexed keywords

EID: 84866114814     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470958209.ch23     Document Type: Chapter

References (170)

1. Albus, A. M., E. C. Pesci, L. J. Runyen-Janecky, S. E. West, and B. H. Iglewski. 1997. Vfr controls quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 179:3928-3935.
2. Alexander, C., and E. T. Rietschel. 2001. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7:167-202.
3. Allewelt, M., F. T. Coleman, M. Grout, G. P. Priebe, and G. B. Pier. 2000. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect. Immun. 68:3998-4004.
4. Aoi, Y., H. Noda, R. Yanagawa, J. Y. Homma, C. Abe, K. Morihara, et al. 1979. Protection against hemorrhagic pneumonia of mink by Pseudomonas aeruginosa multicomponent vaccine. Jpn. J. Exp. Med. 49:199-207.
5. Arnoldo, A., J. Curak, S. Kittanakom, I. Chevelev, V. T. Lee, M. Sahebol-Amri, et al. 2008. Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen. PLoS Genet. 4:e1000005.
6. Azghani, A. O., E. J. Miller and B. T. Peterson. 2000. Virulence factors from Pseudomonas aeruginosa increase lung epithelial permeability. Lung 178:261-269.
7. Barker, A. P., A. I. Vasil, A. Filloux, G. Ball, P. J. Wilderman, and M. L. Vasil. 2004. A novel extracellular phospholipase C of Pseudomonas aeruginosa is required for phospholipid chemotaxis. Mol. Microbiol. 53:1089-1098.
8. Beinlich, K. L., R. Chuanchuen, and H. P. Schweizer. 2001. Contribution of multidrug efflux pumps to multiple antibiotic resistance in veterinary clinical isolates of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 198:129-134.
9. Berk, R. S., D. Brown, I. Coutinho, and D. Meyers. 1987. In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa. Infect. Immun. 55:1728-1730.
10. Brimer, C. D., and T. C. Montie. 1998. Cloning and comparison of fliC genes and identification of glycosylation in the flagellin of Pseudomonas aeruginosa a-type strains. J. Bacteriol. 180:3209-3217.
11. Callahan, L. T., 3rd. 1976. Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum. Infect. Immun. 14:55-61.
12. Chiang, P., L. M. Sampaleanu, M. Ayers, M. Pahuta, P. L. Howell, and L. L. Burrows. 2008. Functional role of conserved residues in the characteristic secretion NTPase motifs of the Pseudomonas aeruginosa type IV pilus motor proteins PilB, PilT and PilU. Microbiology 154:114-126.
13. Chin, J. C., and J. E. Watts. 1988. Biological properties of phospholipase C purified from a fleecerot isolate of Pseudomonas aeruginosa. J. Gen. Microbiol. 134:2567-2575.
14. Chuanchuen, R., W. Wannaprasat, K. Ajariyakhajorn, and H. P. Schweizer. 2008. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis. Microbiol. Immunol. 52:392-398.
15. Coburn, J., S. T. Dillon, B. H. Iglewski, and D. M. Gill. 1989. Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin. Infect. Immun. 57:996-998.
16. Coburn, J., and D. M. Gill. 1991. ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 59:4259-4262.
17. Cole, L. K., K. W. Kwochka, J. J. Kowalski, and A. Hillier. 1998. Microbial flora and antimicrobial susceptibility patterns of isolated pathogens from the horizontal ear canal and middle ear in dogs with otitis media. J. Am. Vet. Med. Assoc. 212:534-538.
18. Comer, J. E., M. A. Marshall, V. J. Blanch, C. D. Deal, and P. Castric. 2002. Identification of the Pseudomonas aeruginosa 1244 pilin glycosylation site. Infect. Immun. 70:2837-2845.
19. Comolli, J. C., A. R. Hauser, L. Waite, C. B. Whitchurch, J. S. Mattick, and J. N. Engel. 1999a. Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia. Infect. Immun. 67:3625-3630.
20. Comolli, J. C., L. L. Waite, K. E. Mostov, and J. N. Engel. 1999b. Pili binding to asialo-GM1 on epithelial cells can mediate cytotoxicity or bacterial internalization by Pseudomonas aeruginosa. Infect. Immun. 67:3207-3214.
21. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
22. Coutinho, I. R., R. S. Berk, and E. Mammen. 1988. Platelet aggregation by a phospholipase C from Pseudomonas aeruginosa. Thromb. Res. 51:495-505.
23. Cryz, S. J., Jr., T. L. Pitt, E. Furer, and R. Germanier. 1984. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect. Immun. 44:508-513.
24. Cryz, S. J., Jr., J. C. Sadoff, A. S. Cross, and E. Furer. 1989. Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A vaccine in humans. Antibiot. Chemother. 42:177-183.
25. Daly, M., E. Power, J. Bjorkroth, P. Sheehan, A. O'Connell, M. Colgan, et al. 1999. Molecular analysis of Pseudomonas aeruginosa: epidemiological investigation of mastitis outbreaks in Irish dairy herds. Appl. Environ. Microbiol. 65:2723-2729.
26. Danner, R. L., C. Natanson, R. J. Elin, J. M. Hosseini, S. Banks, T. J. MacVittie, et al. 1990. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest 98:1480-1487.
27. de Bentzmann, S., P. Roger, F. Dupuit, O. Bajolet-Laudinat, C. Fuchey, M. C. Plotkowski, et al. 1996. Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. Infect. Immun. 64:1582-1588.
28. DeLange, P. A., T. L. Collins, G. E. Pierce, and J. B. Robinson. 2007. PilJ localizes to cell poles and is required for type IV pilus extension in Pseudomonas aeruginosa. Curr. Microbiol. 55:389-395.
29. DiGiandomenico, A., J. Rao, and J. B. Goldberg. 2004. Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model. Infect. Immun. 72:7012-7021.
30. DiGiandomenico, A., J. Rao, K. Harcher, T. S. Zaidi, J. Gardner, A. N. Neely, et al. 2007. Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections. Proc. Natl. Acad. Sci. USA 104:4624-4629.
31. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
32. Döring, G., C. Meisner, and M. Stern. 2007. A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 104:11020-11025.
33. Döring, G., and G. B. Pier. 2008. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine 26:1011-1024.
34. Feldman, M., R. Bryan, S. Rajan, L. Scheffler, S. Brunnert, H. Tang, et al. 1998. Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 66:43-51.
35. Friedman, L., and R. Kolter. 2004a. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol. Microbiol. 51:675-690.
36. Friedman, L., and R. Kolter. 2004b. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J. Bacteriol. 186:4457-4465.
37. Galloway, D. R. 1991. Pseudomonas aeruginosa elastase and elastolysis revisited: recent developments. Mol. Microbiol. 5:2315-2321.
38. Garrity-Ryan, L., B. Kazmierczak, R. Kowal, J. Comolli, A. Hauser, and J. N. Engel. 2000. The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect. Immun. 68:7100-7113.
39. Goehring, U. M., G. Schmidt, K. J. Pederson, K. Aktories, and J. T. Barbieri. 1999. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J. Biol. Chem. 274:36369-36372.
40. Gooderham, W. J., M. Bains, J. B. McPhee, I. Wiegand, and R. E. Hancock. 2008. Induction by cationic antimicrobial peptides and involvement in intrinsic polymyxin and antimicrobial peptide resistance, biofilm formation, and swarming motility of PsrA in Pseudomonas aeruginosa. J. Bacteriol. 190:5624-5634.
41. Govan, J. R., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
42. Gray, L. D., and A. S. Kreger. 1975. Rabbit corneal damage produced by Pseudomonas aeruginosa infection. Infect. Immun. 12:419-432.
43. Gray, L., and A. Kreger. 1979. Microscopic characterization of rabbit lung damage produced by Pseudomonas aeruginosa proteases. Infect. Immun. 23:150-159.
44. Gupta, S. K., R. S. Berk, S. Masinick, and L. D. Hazlett. 1994. Pili and lipopolysaccharide of Pseudomonas aeruginosa bind to the glycolipid asialo GM1. Infect. Immun. 62:4572-4579.
45. Gyles, C. L. 1993. Pseudomonas and Moraxella. In Pathogenesis of Bacterial Infections in Animals, 2nd ed. C. L. Gyles and C. Thoen (eds.). Ames: Iowa State University Press, p. 249.
46. Hamood, A. N., J. A. Griswold, and C. M. Duhan. 1996. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections. J. Surg. Res. 61:425-432.
47. Hancock, R. E., and F. S. Brinkman. 2002. Function of pseudomonas porins in uptake and efflux. Annu. Rev. Microbiol. 56:17-38.
48. Hancock, R. E., and E. A. Worobec. 1998. Outer membrane proteins. Pseudomonas. InBiotechnology handbooks, vol. 10. T. Montie (ed.). London: Plenum Press, pp. 139-167.
49. Hasegawa, H., T. Tanikawa, T. Nozawa, K. Nakazawa, Y. Nakagawa, and T. Matsuyama. 2007. Distinct function of Pseudomonas aeruginosa type IV pili disclosed in the bacterial pass-through of membrane filter with smaller pore sizes. Microbiol. Immunol. 51:429-433.
50. Hauser, A. R., and J. N. Engel. 1999. Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells. Infect. Immun. 67:5530-5537.
51. Hauser, A. R., S. Fleiszig, P. J. Kang, K. Mostov, and J. N. Engel. 1998. Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells. Infect. Immun. 66:1413-1420.
52. Hay, I. D., U. Remminghorst, and B. H. Rehm. 2009. MucR, a novel membrane associated regulator of alginate biosynthesis in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 75:1110-1120.
53. Hendrickson, E. L., J. Plotnikova, S. Mahajan-Miklos, L. G. Rahme, and F. M. Ausubel. 2001. Differential roles of the Pseudomonas aeruginosa PA14 rpoN gene in pathogenicity in plants, nematodes, insects, and mice. J. Bacteriol. 183:7126-7134.
54. Hickman, J. W., and C. S. Harwood. 2008. Identification of FleQ from Pseudomonas aeruginosa as a c-di-GMP-responsive transcription factor. Mol. Microbiol. 69:376-389.
55. Holder, I. A., and C. G. Haidaris. 1979. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors. Can. J. Microbiol. 25:593-599.
56. Homma, J. Y., C. Abe, R. Yanagawa, and H. Noda. 1983. Effectiveness of immunization with multicomponent vaccines in protection against hemorrhagic pneumonia due to Pseudomonas aeruginosa infection in mink. Rev. Infect. Dis. 5(Supplement 5):S858-S866.
57. Howe, T. R., and B. H. Iglewski. 1984. Isolation and characterization of alkaline protease-deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model. Infect. Immun. 43:1058-1063.
58. Iglewski, B. H., and D. Kabat. 1975. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin. Proc. Natl. Acad. Sci. U S A 72:2284-2288.
59. Ishida, T., T. Ikeda, N. Takiguchi, A. Kuroda, H. Ohtake, and J. Kato. 2007. Inhibition of quorum sensing in Pseudomonas aeruginosa by N-acyl cyclopentylamides. Appl. Environ. Microbiol. 73:3183-3188.
60. Jackson, K. D., M. Starkey, S. Kremer, M. R. Parsek, and D. J. Wozniak. 2004. Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J. Bacteriol. 186:4466-4475.
61. Jenssen, H., P. Hamill, and R. E. Hancock. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511.
62. Keizer, D. W., C. M. Slupsky, M. Kalisiak, A. P. Campbell, M. P. Crump, P. A. Sastry, et al. 2001. Structure of a pilin monomer from Pseudomonas aeruginosa: implications for the assembly of pili. J. Biol. Chem. 276:24186-24193.
63. Komori, Y., T. Nonogaki, and T. Nikai. 2001. Hemorrhagic activity and muscle damaging effect of Pseudomonas aeruginosa metalloproteinase (elastase). Toxicon 39:1327-1332.
64. Krall, R., G. Schmidt, K. Aktories, and J. T. Barbieri. 2000. Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect. Immun. 68:6066-6068.
65. Kudoh, I., J. P. Wiener-Kronish, S. Hashimoto, J. F. Pittet, and D. Frank. 1994. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am. J. Physiol. 267:L551-L556.
66. Lam, J., R. Chan, K. Lam, and J. W. Costerton. 1980. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28:546-556.
67. Lang, A. B., A. Rudeberg, M. H. Schoni, J. U. Que, E. Furer, and U. B. Schaad. 2004. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection. Pediatr. Infect. Dis. J. 23:504-510.
68. Langford, D. T., and J. Hiller. 1984. Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis-three year results. Arch. Dis. Child. 59:1131-1134.
69. Lee, V. T., J. M. Matewish, J. L. Kessler, M. Hyodo, Y. Hayakawa, and S. Lory. 2007. Acyclic-di-GMP receptor required for bacterial exopolysaccharide production. Mol. Microbiol. 65:1474-1484.
70. Lindhout, S. T., P. C. Y. Lau, and J. S. Lam. 2009. Truncation in the core oligosaccharide of lipopoly-saccharide affected flagella-mediated motility in Pseudomonas aeruginosa PAO1 via modiulation of cell surface attachment. Microbiology 155:3449-3460.
71. Liu, P. V. 1973. Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A. J. Infect. Dis. 128:506-513.
72. Liu, P. V. 1974. Extracellular toxins of Pseudomonas aeruginosa. J. Infect. Dis. 130 (Supplement): S94-S99.
73. Liu, P. V. 1979. Toxins of Pseudomonas aeruginosa. In Pseudomonas aeruginosa: clinical manifestations of infections and current therapy. R. G. Dogget (ed.). New York: Academic Press, pp. 63-88.
74. Lomholt, J. A., K. Poulsen, and M. Kilian. 2001. Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect. Immun. 69:6284-6295.
75. Long, G. G., A. M. Gallina, and J. R. Gorham. 1980. Pseudomonas pneumonia of mink: pathogenesis, vaccination, and serologic studies. Am. J. Vet. Res. 41:1720-1725.
76. Lynn, W. A., and D. T. Golenbock. 1992. Lipopolysaccharide antagonists. Immunol. Today 13:271-276.
77. Ma, L., K. D. Jackson, R. M. Landry, M. R. Parsek, and D. J. Wozniak. 2006. Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J. Bacteriol. 188:8213-8221.
78. Macfarlane, E. L., A. Kwasnicka, M. M. Ochs, and R. E. Hancock. 1999. PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol. Microbiol. 34:305-316.
79. Maniati, M., A. Ikonomidis, P. Mantzana, A. Daponte, A. N. Maniatis, and S. Pournaras. 2007. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. J. Antimicrob. Chemother. 60:132-135.
80. Marrie, T. J., J. Lam, and J. W. Costerton. 1980. Bacterial adhesion to uroepithelial cells: a morphologic study. J. Infect. Dis. 142:239-246.
81. Masuda, N., E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino. 2000. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:3322-3327.
82. McClure, C. D., and N. L. Schiller. 1992. Effects of Pseudomonas aeruginosa rhamnolipids on human monocyte-derived macrophages. J. Leukoc. Biol. 51:97-102.
83. McPhee, J. B., M. Bains, G. Winsor, S. Lewenza, A. Kwasnicka, M. D. Brazas, et al. 2006. Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa. J. Bacteriol. 188:3995-4006.
84. McPhee, J. B., S. Lewenza, and R. E. Hancock. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50:205-217.
85. Merighi, M., V. T. Lee, M. Hyodo, Y. Hayakawa, and S. Lory. 2007. The second messenger bis-(3'-5')-cyclic-GMP and its PilZ domain-containing receptor Alg44 are required for alginate biosynthesis in Pseudomonas aeruginosa. Mol. Microbiol. 65:876-895.
86. Meyers, D. J., K. C. Palmer, L. A. Bale, K. Kernacki, M. Preston, T. Brown, et al. 1992. In vivo and in vitro toxicity of phospholipase C from Pseudomonas aeruginosa. Toxicon 30:161-169.
87. Miller, M. B., and B. L. Bassler. 2001. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55:165-199.
88. Miller, W. L., M. J. Matewish, D. J. McNally, N. Ishiyama, E. M. Anderson, D. Brewer, et al. 2008. Flagellin glycosylation in Pseudomonas aeruginosa PAK requires the O-antigen biosynthesis enzyme WbpO. J. Biol. Chem. 283:3507-3518.
89. Misfeldt, M. L., P. K. Legaard, S. E. Howell, M. H. Fornella, and R. D. LeGrand. 1990. Induction of interleukin-1 from murine peritoneal macrophages by Pseudomonas aeruginosa exotoxin A. Infect. Immun. 58:978-982.
90. Miyazaki, S., T. Matsumoto, K. Tateda, A. Ohno, and K. Yamaguchi. 1995. Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice. J. Med. Microbiol. 43:169-175.
91. Montie, T. C., D. Drake, H. Sellin, O. Slater, and S. Edmonds. 1987. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection. Antibiot. Chemother. 39:233-248.
92. Morimoto, H., and B. Bonavida. 1992. Diphtheria toxin-and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. J. Immunol. 149:2089-2094.
93. Moskowitz, S. M., R. K. Ernst, and S. I. Miller. 2004. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186:575-579.
94. Nehme, D., and K. Poole. 2007. Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors. J. Bacteriol. 189:6118-6127.
95. Newman, S. J., R. Johnson, W. Sears, and B. Wilcock. 2002. Investigation of repeated vaccination as a possible cause of glomerular disease in mink. Can. J. Vet. Res. 66:158-164.
96. Nicas, T. I., and B. H. Iglewski. 1985. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Can. J. Microbiol. 31:387-392.
97. Ostroff, R. M., B. Wretlind, and M. L. Vasil. 1989. Mutations in the hemolytic-phospholipase C operon result in decreased virulence of Pseudomonas aeruginosa PAO1 grown under phosphate-limiting conditions. Infect. Immun. 57:1369-1373.
98. Parkins, M. D., H. Ceri, and D. G. Storey. 2001. Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation. Mol. Microbiol. 40:1215-1226.
99. Parmely, M., A. Gale, M. Clabaugh, R. Horvat, and W. W. Zhou. 1990. Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect. Immun. 58:3009-3014.
100. Parsek, M. R., and E. P. Greenberg. 2000. Acyl-homoserine lactone quorum sensing in gram-negative bacteria: a signaling mechanism involved in associations with higher organisms. Proc. Natl. Acad. Sci. U S A 97:8789-8793.
101. Pavlovskis, O. R., L. T. Callahan, and M. Pollack. 1975. Pseudomonas aeruginosa exotoxin. In Microbiology. D. Schlessinger (ed.). Washington, DC: American Society for Microbiology, pp. 252-256.
102. Pennington, J. E., H. Y. Reynolds, R. E. Wood, R. A. Robinson, and A. S. Levine. 1975. Use of a Pseudomonas aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis. Am. J. Med. 58:629-636.
103. Petermann, S. R., C. Doetkott, and L. Rust. 2001. Elastase deficiency phenotype of Pseudomonas aeruginosa canine otitis externa isolates. Clin. Diagn. Lab. Immunol. 8:632-636.
104. Pier, G. B., M. Grout, T. S. Zaidi, J. C. Olsen, L. G. Johnson, J. R. Yankaskas, et al. 1996. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271:64-67.
105. Pier, G. B., G. Meluleni, and E. Neuger. 1992. A murine model of chronic mucosal colonization by Pseudomonas aeruginosa. Infect. Immun. 60:4768-4776.
106. Pillar, C. M., L. D. Hazlett, and J. A. Hobden. 2000. Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye. Curr. Eye Res. 21:730-739.
107. Pillar, C. M., and J. A. Hobden. 2002. Pseudomonas aeruginosa exotoxin A and keratitis in mice. Invest. Ophthalmol. Vis. Sci. 43:1437-1444.
108. Pittet, J. F., J. P. Wiener-Kronish, V. Serikov, and M. A. Matthay. 1995. Resistance of the alveolar epithelium to injury from septic shock in sheep. Am. J. Respir. Crit. Care Med. 151:1093-1100.
109. Plotkowski, M. C., H. C. Povoa, J. M. Zahm, G. Lizard, G. M. Pereira, J. M. Tournier, et al. 2002. Early mitochondrial dysfunction, superoxide anion production, and DNA degradation are associated with non-apoptotic death of human airway epithelial cells induced by Pseudomonas aeruginosa exotoxin A. Am. J. Respir. Cell Mol. Biol. 26:617-626.
110. Pollack, M., and L. S. Young. 1979. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J. Clin. Invest. 63:276-286.
111. Poole, K. 2001. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol. 3:255-264.
112. Poole, K., and R. Srikumar. 2001. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top. Med. Chem. 1:59-71.
113. Poon, K. K., E. L. Westman, E. Vinogradov, S. Jin, and J. S. Lam. 2008. Functional characterization of MigA and WapR: putative rhamnosyltransferases involved in outer core oligosaccharide biosynthesis of Pseudomonas aeruginosa. J. Bacteriol. 190:1857-1865.
114. Preston, M. J., S. M. Fleiszig, T. S. Zaidi, J. B. Goldberg, V. D. Shortridge, M. L. Vasil, et al. 1995. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect. Immun. 63:3497-3501.
115. Quinn, J. P., A. E. Studemeister, C. A. DiVincenzo, and S. A. Lerner. 1988. Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Rev. Infect. Dis. 10:892-898.
116. Rahme, L. G., F. M. Ausubel, H. Cao, E. Drenkard, B. C. Goumnerov, G. W. Lau, et al. 2000. Plants and animals share functionally common bacterial virulence factors. Proc. Natl. Acad. Sci. U S A 97:8815-8821.
117. Rasmussen, T. B., T. Bjarnsholt, M. E. Skindersoe, M. Hentzer, P. Kristoffersen, M. Kote, et al. 2005. Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J. Bacteriol. 187:1799-1814.
118. Read, R. C., P. Roberts, N. Munro, A. Rutman, A. Hastie, T. Shryock, et al. 1992. Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J. Appl. Physiol. 72:2271-2277.
119. Reimmann, C., M. Beyeler, A. Latifi, H. Winteler, M. Foglino, A. Lazdunski, et al. 1997. The global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipase. Mol. Microbiol. 24:309-319.
120. Rocchetta, H. L., L. L. Burrows, and J. S. Lam. 1999. Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 63:523-553.
121. Rosenthal, V. D., D. G. Maki, A. Mehta, C. Alvarez-Moreno, H. Leblebicioglu, F. Higuera, et al. 2008. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am. J. Infect. Control 36:627-637.
122. Rubin, J., R. D. Walker, K. Blickenstaff, S. Bodeis-Jones, and S. Zhao. 2008. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections. Vet. Microbiol. 131:164-172.
123. Ryder, C., M. Byrd, and D. J. Wozniak. 2007. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr. Opin. Microbiol. 10:644-648.
124. Sadovskaya, I., J. R. Brisson, J. S. Lam, J. C. Richards, and E. Altman. 1998. Structural elucidation of the lipopolysaccharide core regions of the wild-type strain PAO1 and O-chain-deficientmutant strains AK1401 and AK1012 from Pseudomonas aeruginosa serotype O5. Eur. J. Biochem. 255:673-684.
125. Saiman, L., and A. Prince. 1993. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 92:1875-1880.
126. Sato, H., D. W. Frank, C. J. Hillard, J. B. Feix, R. R. Pankhaniya, K. Moriyama, et al. 2003. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J. 22:2959-2969.
127. Sato, H., K. Okinaga, and H. Saito. 1988. Role of pili in the pathogenesis of Pseudomonas aeruginosa burn infection. Microbiol. Immunol. 32:131-139.
128. Sawa, T., T. L. Yahr, M. Ohara, K. Kurahashi, M. A. Gropper, J. P. Wiener-Kronish, et al. 1999. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat. Med. 5:392-398.
129. Scarff, J. M., and J. B. Goldberg. 2008. Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice. Clin. Vaccine Immunol. 15:367-375.
130. Scharfman, A., S. K. Arora, P. Delmotte, E. Van Brussel, J. Mazurier, R. Ramphal, et al. 2001. Recognition of Lewis X derivatives present on mucins by flagellar components of Pseudomonas aeruginosa. Infect. Immun. 69:5243-5248.
131. Schirm, M., S. K. Arora, A. Verma, E. Vinogradov, P. Thibault, R. Ramphal, et al. 2004. Structural and genetic characterization of glycosylation of type a flagellin in Pseudomonas aeruginosa. J. Bacteriol. 186:2523-2531.
132. Seol, B., T. Naglic, J. Madic, and M. Bedekovic. 2002. In vitro antimicrobial susceptibility of 183 Pseudomonas aeruginosa strains isolated from dogs to selected antipseudomonal agents. J. Vet. Med. B Infect. Dis. Vet. Public Health 49:188-192.
133. Shafikhani, S. H., C. Morales, and J. Engel. 2008. The Pseudomonas aeruginosa type III secreted toxin ExoT is necessary and sufficient to induce apoptosis in epithelial cells. Cell. Microbiol. 10:994-1007.
134. Skindersoe, M. E., M. Alhede, R. Phipps, L. Yang, P. O. Jensen, T. B. Rasmussen, et al. 2008. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52:3648-3663.
135. Smedley, J. G., 3rd, E. Jewell, J. Roguskie, J. Horzempa, A. Syboldt, D. B. Stolz, et al. 2005. Influence of pilin glycosylation on Pseudomonas aeruginosa 1244 pilus function. Infect. Immun. 73:7922-7931.
136. Smith, R. S., and B. H. Iglewski. 2003. P. aeruginosa quorum-sensing systems and virulence. Curr. Opin. Microbiol. 6:56-60.
137. Soberón-Chavez, G., F. Lepine, and E. Deziel. 2005. Production of rhamnolipids by Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol. 68:718-725.
138. Soscia, C., A. Hachani, A. Bernadac, A. Filloux, and S. Bleves. 2007. Cross talk between type III secretion and flagellar assembly systems in Pseudomonas aeruginosa. J. Bacteriol. 189:3124-3132.
139. Staugas, R. E., D. P. Harvey, A. Ferrante, M. Nandoskar, and A. C. Allison. 1992. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes. Infect. Immun. 60:3162-3168.
140. Stepinska, M., and E. A. Trafny. 2008. Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines. Microb. Pathog. 44:448-458.
141. Sun, J., and J. T. Barbieri. 2003. Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins. J. Biol. Chem. 278:32794-32800.
142. Sundin, C., M. L. Henriksson, B. Hallberg, A. Forsberg, and E. Frithz-Lindsten. 2001. Exoenzyme T of Pseudomonas aeruginosa elicits cytotoxicity without interfering with Ras signal transduction. Cell. Microbiol. 3:237-246.
143. Tang, H., M. Kays, and A. Prince. 1995. Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect. Immun. 63:1278-1285.
144. Toder, D. S., M. J. Gambello, and B. H. Iglewski. 1991. Pseudomonas aeruginosa LasA: a second elastase under the transcriptional control of lasR. Mol. Microbiol. 5:2003-2010.
145. Tümmler, B. 2006. Clonal variations in Pseudomonas aeruginosa. In Pseudomonas, vol. 4. J. L. Ramos and R. C. Levesque (eds.). Heidelberg, Germany: Springer, pp. 35-68.
146. Vance, R. E., A. Rietsch, and J. J. Mekalanos. 2005. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect. Immun. 73:1706-1713.
147. Van Delden, C., and B. H. Iglewski. 1998. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg. Infect. Dis. 4:551-560.
148. Vasseur, P., I. Vallet-Gely, C. Soscia, S. Genin, and A. Filloux. 2005. The pel genes of the Pseudomonas aeruginosa PAK strain are involved at early and late stages of biofilm formation. Microbiology 151:985-997.
149. Venturi, V. 2006. Regulation of quorum sensing in Pseudomonas. FEMS Microbiol. Rev. 30:274-291.
150. Verma, A., M. Schirm, S. K. Arora, P. Thibault, S. M. Logan, and R. Ramphal. 2006. Glycosylation of b-Type flagellin of Pseudomonas aeruginosa: structural and genetic basis. J. Bacteriol. 188:4395-4403.
151. Viducic, D., T. Ono, K. Murakami, M. Katakami, H. Susilowati, and Y. Miyake. 2007. rpoN gene of Pseudomonas aeruginosa alters its susceptibility to quinolones and carbapenems. Antimicrob. Agents Chemother. 51:1455-1462.
152. Voisin, S., J. V. Kus, S. Houliston, F. St. Michael, D. Watson, D. G. Cvitkovitch, et al. 2007. Glycosylation of Pseudomonas aeruginosa strain Pa5196 type IV pilins with mycobacterium-like alpha-1,5-linked d-Araf oligosaccharides. J. Bacteriol. 189:151-159.
153. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-beta-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
154. Wang, J., S. Lory, R. Ramphal, and S. Jin. 1996. Isolation and characterization of Pseudomonas aeruginosa genes inducible by respiratory mucus derived from cystic fibrosis patients. Mol. Microbiol. 22:1005-1012.
155. Wargo, M. J., T. C. Ho, M. J. Gross, L. A. Whittaker, and D. A. Hogan. 2008. GbdR regulates Pseudomonas aeruginosa plcH and pchP transcription in response to choline catabolites. Infect. Immun. 77:1103-1111.
156. Watson, P. J., X. Jiru, M. Watabe, and J. E. Moore. 2003. Purulent rhinitis and otitis caused by Pseudomonas aeruginosa in sheep showered with contaminated "shower wash." Vet. Rec. 153:704-707.
157. Westman, E. L., A. Preston, R. A. Field, and J. S. Lam. 2008. Biosynthesis of a rare di-N-acetylated sugar in the lipopolysaccharide of both Pseudomonas aeruginosa and Bordetella pertussis occurs via an identical scheme despite different gene clusters. J. Bacteriol. 190:6060-6069.
158. Westman, E. L., D. J. McNally, M. Rejzek, W. L. Miller, V. S. Kannathasan, A. Preston, et al. 2007. Identification and biochemical characterization of two novel UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronic acid 2-epimerases from respiratory pathogens. Biochem. J. 405:123-130.
159. Wiehlmann, L., A. Munder, T. Adams, M. Juhas, H. Kolmar, P. Salunkhe, et al. 2007a. Functional genomics of Pseudomonas aeruginosa to identify habitat-specific determinants of pathogenicity. Int. J. Med. Microbiol. 297:615-623.
160. Wiehlmann, L., G. Wagner, N. Cramer, B. Siebert, P. Gudowius, G. Morales, et al. 2007b. Population structure of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 104:8101-8106.
161. Wiener-Kronish, J. P., T. Sakuma, I. Kudoh, J. F. Pittet, D. Frank, L. Dobbs, et al. 1993. Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J. Appl. Physiol. 75:1661-1669.
162. Winsor, G. L., R. Lo, S. J. Sui, K. S. Ung, S. Huang, D. Cheng, et al. 2005. Pseudomonas aeruginosa Genome Database and PseudoCAP: facilitating community-based, continually updated, genome annotation. Nucleic Acids Res. 33:D338-D343.
163. Wolf, P., and U. Elsasser-Beile. 2008. Pseudomonas exotoxin A: from virulence factor to anti-cancer agent. Int. J. Med. Microbiol. 299:161-176.
164. Woods, D. E., D. C. Straus, W. G. Johanson, Jr., V. K. Berry, and J. A. Bass. 1980. Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect. Immun. 29:1146-1151.
165. Wozniak, D. J., and D. E. Ohman. 1994. Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB, and algD reveals a hierarchy of alginate gene expression which is modulated by algT. J. Bacteriol. 176:6007-6014.
166. Wozniak, D. J., T. J. Wyckoff, M. Starkey, R. Keyser, P. Azadi, G. A. O'Toole, et al. 2003. Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc. Natl. Acad. Sci. USA 100:7907-7912.
167. Yahr, T. L., A. J. Vallis, M. K. Hancock, J. T. Barbieri, and D. W. Frank. 1998. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. U S A 95:13899-13904.
168. Yang, H., M. Matewish, I. Loubens, D. G. Storey, J. S. Lam, and S. Jin. 2000. migA, a quorumresponsive gene of Pseudomonas aeruginosa, is highly expressed in the cystic fibrosis lung environment and modifies low-molecular-mass lipopolysaccharide. Microbiology 146:2509-2519.
169. Zaidi, T. S., S. M. Fleiszig, M. J. Preston, J. B. Goldberg, and G. B. Pier. 1996. Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa. Invest. Ophthalmol. Vis. Sci. 37:976-986.
170. Zolfaghar, I., D. J. Evans, and S. M. Fleiszig. 2003. Twitching motility contributes to the role of pili in corneal infection caused by Pseudomonas aeruginosa. Infect. Immun. 71:5389-5393.